期刊中(zhong)文名:國際生物醫(yi)學(xue)工程與(yu)技術雜志(zhi)ISSN:1752-6418E-ISSN:1752-6426
該(gai)雜(za)志國際簡(jian)稱:INT J BIOMED ENG TEC,是由出版商Inderscience Publishers出版的(de)(de)一(yi)(yi)本致力于發(fa)布(bu)--研(yan)究新(xin)成果的(de)(de)的(de)(de)專(zhuan)業學術(shu)期刊。主要(yao)發(fa)表刊登(deng)有(you)創見(jian)的(de)(de)學術(shu)論(lun)文(wen)文(wen)章、行(xing)業最新(xin)科(ke)研(yan)成果,扼要(yao)報(bao)道階(jie)段性研(yan)究成果和重要(yao)研(yan)究工作的(de)(de)最新(xin)進(jin)展(zhan),選載對(dui)學科(ke)發(fa)展(zhan)起指導作用的(de)(de)綜述與專(zhuan)論(lun),促(cu)進(jin)學術(shu)發(fa)展(zhan),為廣(guang)大(da)讀者(zhe)服務。該(gai)刊是一(yi)(yi)本國際優秀雜(za)志,在(zai)國際上有(you)很(hen)高的(de)(de)學術(shu)影響力。
《International Journal Of Biomedical Engineering And Technology》是一本以(yi)English為主的(de)(de)未(wei)開放獲取國(guo)際優秀期刊(kan),中文(wen)名稱國(guo)際生物醫學(xue)工程與(yu)技術雜志,本刊(kan)主要出(chu)版、報道領(ling)域(yu)的(de)(de)研究動(dong)(dong)態(tai)以(yi)及在(zai)該(gai)領(ling)域(yu)取得的(de)(de)各方(fang)面的(de)(de)經驗和科(ke)研成果,介紹該(gai)領(ling)域(yu)有(you)關本專業(ye)的(de)(de)最新進(jin)展(zhan)(zhan),探討行業(ye)發展(zhan)(zhan)的(de)(de)思路和方(fang)法,以(yi)促(cu)進(jin)學(xue)術信息交流(liu),提高行業(ye)發展(zhan)(zhan)。該(gai)刊(kan)已被國(guo)際權威數(shu)據庫SCIE收錄,為該(gai)領(ling)域(yu)相關學(xue)科(ke)的(de)(de)發展(zhan)(zhan)起到了良好的(de)(de)推動(dong)(dong)作用(yong),也得到了本專業(ye)人員的(de)(de)廣泛(fan)認可。該(gai)刊(kan)最新影響因子為0.7,最新CiteScore 指數(shu)為1.6。
The International Journal of Biomedical Engineering and Technology is an international academic journal dedicated to the field of biomedical engineering and technology. This journal is committed to publishing high-quality research results, aiming to promote innovation and progress in the field of biomedical engineering. It provides a platform for scholars, researchers, engineers, and medical professionals to exchange the latest discoveries, technological developments, and applied research. The journal covers a wide range of sub fields in biomedical engineering, including but not limited to biomaterials, biomechanics, biological signal processing, biosensors, bioimaging technology, clinical engineering, tissue engineering, nanomedicine, regenerative medicine, bioelectronics, bioinformatics, and related computational methods. IJ BET encourages interdisciplinary research and promotes the integration of biomedical engineering with fields such as computer science, materials science, chemistry, physics, and biology.
This journal places special emphasis on the practical application of research findings and their contributions to the field of healthcare. The types of articles include original research papers, review articles, technical reports, and case studies, which not only reflect the current research hotspots in the field of biomedical engineering, but also demonstrate the potential of technological progress in this field to improve human health and quality of life. The magazine also pays special attention to the application of emerging technologies in biomedical engineering, such as artificial intelligence, machine learning, and big data analysis in disease diagnosis, treatment planning, and patient monitoring. In addition, the journal also focuses on issues such as ethics, law, and social impact, emphasizing that while promoting technological progress, its broad impact on society should also be considered.
按(an)JIF指標學科(ke)分(fen)區(qu) |
學科:ENGINEERING, BIOMEDICAL
收錄子集:ESCI
分區:Q4
排名:117 / 122
百分位:
4.5% |
按(an)JCI指(zhi)標(biao)學科分區 |
學科:ENGINEERING, BIOMEDICAL
收錄子集:ESCI
分區:Q4
排名:117 / 122
百分位:
4.51% |
JCR分區:JCR分(fen)區來(lai)自科睿(rui)唯安公(gong)司,JCR是一個(ge)(ge)(ge)獨特的(de)多學科期(qi)刊(kan)評價(jia)工具,為唯一提供基于引文數(shu)據(ju)的(de)統計(ji)信息的(de)期(qi)刊(kan)評價(jia)資源。每年(nian)發布的(de)JCR分(fen)區,設置了254個(ge)(ge)(ge)具體學科。JCR分(fen)區根據(ju)每個(ge)(ge)(ge)學科分(fen)類按照(zhao)期(qi)刊(kan)當年(nian)的(de)影響因(yin)子高低將期(qi)刊(kan)平均分(fen)為4個(ge)(ge)(ge)區,分(fen)別為Q1、Q2、Q3和Q4,各占25%。JCR分(fen)區中期(qi)刊(kan)的(de)數(shu)量是均勻分(fen)為四個(ge)(ge)(ge)部分(fen)的(de)。
學科類別 | 分區 | 排名 | 百分位 |
大類:Engineering 小類:Biomedical Engineering | Q4 | 240 / 303 |
20% |
該雜(za)(za)(za)志(zhi)(zhi)是一本國(guo)際(ji)優秀(xiu)雜(za)(za)(za)志(zhi)(zhi),在(zai)國(guo)際(ji)上有較(jiao)高(gao)的(de)學術影(ying)響力(li),行業關注(zhu)度很高(gao),已(yi)被(bei)國(guo)際(ji)權(quan)威(wei)數據(ju)庫SCIE收錄(lu),該雜(za)(za)(za)志(zhi)(zhi)在(zai)綜合專(zhuan)業領(ling)域專(zhuan)業度認可(ke)很高(gao),對稿(gao)(gao)件內容的(de)創新性和(he)學術性要求很高(gao),作為一本國(guo)際(ji)優秀(xiu)雜(za)(za)(za)志(zhi)(zhi),一般投(tou)(tou)(tou)稿(gao)(gao)過(guo)審(shen)時間都(dou)較(jiao)長,投(tou)(tou)(tou)稿(gao)(gao)過(guo)審(shen)時間平均 ,如果想投(tou)(tou)(tou)稿(gao)(gao)該刊(kan)要做好時間安排。版面費不祥。該雜(za)(za)(za)志(zhi)(zhi)近兩年未被(bei)列入預警名單,建議您投(tou)(tou)(tou)稿(gao)(gao)。如您想了解更(geng)多投(tou)(tou)(tou)稿(gao)(gao)政(zheng)策及(ji)投(tou)(tou)(tou)稿(gao)(gao)方案,請(qing)咨詢客服。
若用(yong)戶需要出版服務,請聯系出版商。